Results 1 to 10 of about 81,908 (295)

gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES

Annual Review of Immunology, 1997
Tadamitsu Kishimoto, Tetsuya Taga
exaly  

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Nature Reviews Drug Discovery, 2012
Charles A. Dinarello, Anna Simon
exaly  

Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis

European Heart Journal, 2020
Tom Thuren, Peter Libby
exaly  

Interleukin-22: Immunobiology and Pathology

Annual Review of Immunology, 2015
Jarrod Dudakov, Alan M Hanash
exaly  

Cellular sources and immune functions of interleukin-9

Nature Reviews Immunology, 2010
Randolph Noelle
exaly  

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology

Nature, 2010
Kevin Maloy, Philip P Ahern, Dan Littman
exaly  

Interleukin-21: a double-edged sword with therapeutic potential

Nature Reviews Drug Discovery, 2014
Warren J Leonard, Rosanne Spolski
exaly  

Interleukin-6 family of cytokines and gp130

Blood, 1995
Shizuo Akira, Masashi Narazaki, Tetsuya Taga   +2 more
exaly  

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

Journal of Experimental Medicine, 1994
William E Carson, Michael A. Caligiuri
exaly  

Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients

Neuroscience Letters, 1995
Wilfried Kuhn, H Przuntek
exaly